Although, the inactivation of BRG1 and P53 as well as the activation of oncogenic KRAS resulted in highly penetrant lung adenocarcinomas compared to the inactivation of just p53 and activation of oncogenic KRAS. The gene discussed is KRAS; the disease is lung adenocarcinoma.